CINECA IRIS Institutional Research Information System

BONUCCELLI, UBALDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.042
EU - Europa 11.395
AS - Asia 4.587
AF - Africa 439
OC - Oceania 66
SA - Sud America 38
Continente sconosciuto - Info sul continente non disponibili 11
Totale 45.578
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.300
IT - Italia 4.603
CN - Cina 2.129
SE - Svezia 1.925
BG - Bulgaria 1.193
SG - Singapore 989
DE - Germania 988
CA - Canada 733
TR - Turchia 579
GB - Regno Unito 573
UA - Ucraina 542
VN - Vietnam 477
FI - Finlandia 458
AT - Austria 275
CH - Svizzera 231
CI - Costa d'Avorio 203
RU - Federazione Russa 176
IN - India 149
HK - Hong Kong 146
FR - Francia 141
NG - Nigeria 139
SN - Senegal 73
BE - Belgio 65
PL - Polonia 50
AU - Australia 49
NL - Olanda 44
KR - Corea 28
CZ - Repubblica Ceca 26
BR - Brasile 23
TW - Taiwan 18
NZ - Nuova Zelanda 17
IE - Irlanda 16
ES - Italia 15
GR - Grecia 15
JP - Giappone 14
IL - Israele 12
IR - Iran 11
EU - Europa 10
ID - Indonesia 10
RO - Romania 10
BJ - Benin 9
HU - Ungheria 8
DK - Danimarca 7
CO - Colombia 6
HR - Croazia 6
LT - Lituania 6
MX - Messico 6
EE - Estonia 5
PE - Perù 5
ZA - Sudafrica 5
EG - Egitto 4
PT - Portogallo 4
AR - Argentina 3
BN - Brunei Darussalam 3
IQ - Iraq 3
MY - Malesia 3
NO - Norvegia 3
BA - Bosnia-Erzegovina 2
MA - Marocco 2
PH - Filippine 2
SA - Arabia Saudita 2
TH - Thailandia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CU - Cuba 1
DZ - Algeria 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TZ - Tanzania 1
UZ - Uzbekistan 1
Totale 45.578
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.155
Fairfield 3.473
Ann Arbor 2.740
Houston 2.580
Chandler 2.014
Ashburn 1.781
Seattle 1.459
Serra 1.287
Cambridge 1.225
Sofia 1.190
Wilmington 1.177
Milan 967
Jacksonville 779
New York 722
Beijing 721
Ottawa 687
Singapore 532
Princeton 526
Boardman 512
Lawrence 462
Medford 437
Izmir 370
Nanjing 355
Des Moines 313
Santa Clara 295
Vienna 262
Dearborn 242
Florence 219
Bern 213
Abidjan 203
Istanbul 195
Dong Ket 192
Pisa 168
Nanchang 156
San Diego 149
Jüchen 145
Redwood City 140
Frankfurt am Main 139
Lagos 139
Lancaster 128
Hong Kong 124
Rome 107
Kunming 98
London 93
Bremen 90
Norwalk 83
Ogden 75
Shenyang 75
Dakar 73
Boulder 63
Pune 63
Hebei 62
Brussels 56
Changsha 56
Guangzhou 48
Tianjin 47
Shanghai 46
Jiaxing 44
Los Angeles 43
Hefei 42
Fuzhou 38
Washington 36
Warsaw 32
Dallas 28
Hangzhou 28
Quanzhou 28
Auburn Hills 25
Düsseldorf 23
Phoenix 23
Nürnberg 22
Vicopisano 22
Verona 21
Jinan 20
Orange 20
Trieste 20
Chicago 19
Livorno 19
Munich 19
Detroit 18
Kent 17
Torino 17
Falls Church 14
Lucca 14
Massa 14
Melbourne 14
Radomsko 14
Auckland 13
Cascina 13
Shenzhen 13
Central District 12
Changchun 12
Chengdu 12
San Francisco 12
Helsinki 11
Tappahannock 11
Toronto 11
Wuhan 11
Bergamo 10
Bologna 10
Council Bluffs 10
Totale 35.563
Salva come PNG Salva come JPEG
Nome #
Il fenomeno dell'abitudine del riflesso trigemino-faciale: confronto tra malattia di Parkinson e atrofia multisistemica. 388
Actigraphic sleep detection: an artificial intelligence approach 303
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 247
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 219
Occurrence of seizures and EEG interictal epileptiform discharges in AD patients and their correlation with clinical features: a cross-sectional study 188
Descrizione di un caso di Neuromiotonia associata a tetania normocalcemica 181
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 181
Novel MTCYB mutation in a young patient with recurrent stroke-like episodes and status epilepticus. 180
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 179
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 179
Epilepsy occurrence in patients with Alzheimer's disease: clinical experience in a tertiary dementia center 171
A case of pelvic floor myoclonic jerk syndrome. 165
Endothelium and oxidative stress: The Pandora's Box of cerebral (and non-only) small vessel disease? 165
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease 162
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 160
Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily 156
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study 153
Intra-arterial tissue plasminogen activator and abciximab in patients with acute basilar artery occlusion 152
Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease 152
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 152
Mapping Cortical Degeneration in ALS with Magnetization Transfer Ratio and Voxel-Based Morphometry 151
Sleep Disorders in an elderly population and their relationship with cognitive symptoms: an epidemiological survey 151
Chronic Migraine with Medication Overuse and OnabotulinumtoxinA: Two Positive Case Reports of a Modified Injection Protocol 150
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 150
Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation 150
Acute and chronic effects of clozapine in essential tremor 149
Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients 149
The Neuroanatomy of the Reticular Nucleus Locus Coeruleus in Alzheimer's Disease. 148
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. 147
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction 147
Activity-based diary for Parkinson's disease, 146
A whole-brain analysis in de novo Parkinson disease 146
Cyclic alternating pattern and interictal epileptiform discharges during morning sleep after sleep deprivation in temporal lobe epilepsy 146
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 145
DISRUPTION OF SLEEP-WAKE CONTINUUM IN MYOTONIC DYSTROPHY TYPE I: SLEEP MACROSTRUCTURAL AND MICROSTRUCTURAL FINDINGS 144
Cerebellar ataxia with complete clinical recovery and resolution of MRI lesions related to central pontine myelinolysis: case report and literature review 143
The precuneus-a witness for excessive aβ gathering in alzheimer's disease pathology 143
Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation. 142
Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study 141
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 141
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia 140
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. 140
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 139
Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal ig synthesis in multiple sclerosis patients 139
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 139
Role of dopamine agonists in Parkinson's disease: an update 138
A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis 138
Reduced luteinizing hormone secretion in women with Parkinson's disease 137
Effect of metadoxine on striatal dopamine levels in C57 black mice 137
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients 136
Spectrum of addictions in Parkinson's disease: from dopamine dysregulation syndrome to impulse control disorders 136
Perioperative atrial fibrillation and the long-term risk of ischemic stroke 136
A case of sarcoidosis presenting as a non-specific intramedullary lesion 135
Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study 135
Thyroid function and oral TRH in amyotrophic lateral sclerosis 134
IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study 134
Dopamine agonists in the treatment of Parkinson's disease 133
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum. 133
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial 132
Prefrontal cortex, dopamine, and jealousy endophenotype. 132
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes 132
SUNA syndrome with seasonal pattern 132
Postpartum headache due to spontaneous cervical artery dissection 132
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 132
Nummular headache dramatically responsive to indomethacin 130
Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study. 130
SSRIs do not worsen Parkinson's disease: Evidence from an open-label, prospective study 129
Evidences of Reduced Antioxidant Activity in Patients with Chronic Migraine and Medication-Overuse Headache 129
Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. 129
Aerobic rehabilitation program for improving muscle function in Parkinson's disease 129
Acute encephalopathy of the temporal lobes leading to m.3243A>G. When MELAS is not always MELAS 128
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation 127
Clinical pharmacokinetics of cabergoline 126
Event-based prospective memory in newly diagnosed, drug-naive Parkinson's disease patients 126
Cerebral sinus venous thrombosis: Clinical and pathogenetic perspectives from Tuscany 126
Iowa gambling task in Parkinson's disease 125
Iowa Gambling Task in de novo Parkinson's disease: a comparison between good and poor performers 125
Efficacy of a combined therapeutic approach in the management of Pisa Syndrome 125
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study 125
null 125
Association Between CSF Beta-Amyloid and Apathy in Early-Stage Alzheimer Disease 125
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease 124
Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1 124
Levodopa in the treatment of Parkinson's disease: current controversies 123
Decision making in de novo Parkinson's disease 123
Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology. 123
Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats 122
Species differences in the role of excitatory amino acids in experimental parkinsonism. 122
Preferential occurrence of attacks during night sleep and/or upon awakening negatively affects migraine clinical presentation 122
Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test 121
Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers 121
null 121
COMPARISON OF THE EFFECTS OF BARBEXACLONE AND PHENOBARBITAL ON EPILEPTIC PATIENTS 120
Clinical and pharmacokinetic evaluation of L-dopa and cabergoline cotreatment in Parkinson's disease, 120
Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists 120
The association between motor subtypes and alexithymia in de novo Parkinson's disease. 120
Depressive symptoms in Parkinson's disease 120
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 120
Epidemiology and cerebrovascular events related to cervical and intracranial arteries dissection: the experience of the city of Pisa 119
Myopathic involvement in two cases of Hallervorden-Spatz disease 118
Totale 14.475
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.693
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.693
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.275 0 0 0 0 924 1.083 1.124 783 987 539 650 185
2020/20214.108 363 266 273 195 528 249 301 364 372 348 244 605
2021/20224.925 85 206 101 328 992 673 97 273 338 142 262 1.428
2022/20236.201 756 746 418 522 824 833 56 465 1.017 35 439 90
2023/20244.638 637 502 564 277 622 886 183 185 80 83 198 421
2024/20251.861 56 532 145 719 409 0 0 0 0 0 0 0
Totale 46.320